Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2020

Jan 2, 2020

29819_dirs_2020-01-02_34cd5be2-1592-4ba3-8b13-a94884008089.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2020-01-02

Reporting Person: AMGEN INC (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 206635013 Direct

Footnotes

F1: Reported securities are represented by American Depositary Shares, each of which represents 13 Ordinary Shares of the Issuer.